Skip to main content
. 2015 Aug 26;1:15030. doi: 10.1038/npjschz.2015.30

Table 1. Demographics.

  CHR+ (N=5) CHR− (N=29)
Age (in years) 22.2 (3.4) 21.2 (3.6)
Gender (% male) 80% 66%
Race (% Caucasian) 40% 38%
Medications prescribed (antipsychotics and/or antidepressants) 20% 21%

Abbreviations: CHR+, clinical high-risk participants who transitioned to psychosis during follow-up; CHR−, clinical high-risk participants who did not transition to psychosis during follow-up.